|
G |
ENPEP |
glutamyl aminopeptidase |
multiple interactions increases hydrolysis |
EXP |
1,10-phenanthroline inhibits the reaction [ENPEP protein results in increased hydrolysis of Aspartame]; amastatin inhibits the reaction [ENPEP protein results in increased hydrolysis of Aspartame]; Calcium Chloride promotes the reaction [ENPEP protein results in increased hydrolysis of Aspartame] |
CTD |
PMID:8141778 |
|
NCBI chr 8:111,765,839...111,858,349
Ensembl chr 8:111,748,514...111,858,510
|
|
|
G |
CAT |
catalase |
multiple interactions |
EXP |
CAT protein inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide] |
CTD |
PMID:21984542 |
|
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
HMOX1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide; chromium mesoporphyrin inhibits the reaction [[HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide]; tin protoporphyrin IX inhibits the reaction [[HMOX1 protein results in increased metabolism of Heme] which results in increased abundance of Carbon Monoxide] |
CTD |
PMID:16751286 |
|
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
EXP |
NFKBIA protein inhibits the reaction [Carbon Monoxide results in decreased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr 7:64,508,119...64,510,754
Ensembl chr 7:64,507,822...64,511,277
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP |
NFKBIA protein inhibits the reaction [Carbon Monoxide results in decreased susceptibility to TNF protein] |
CTD |
PMID:11880364 |
|
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
G |
XDH |
xanthine dehydrogenase |
multiple interactions |
EXP |
[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide; CAT protein inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide]; tempol inhibits the reaction [[Hypoxanthine co-treated with XDH protein] results in increased chemical synthesis of Carbon Monoxide] |
CTD |
PMID:21984542 |
|
NCBI chr 3:107,987,060...108,052,043
Ensembl chr 3:107,987,126...108,053,169
|
|
|
G |
CAT |
catalase |
multiple interactions |
EXP |
[Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] promotes the reaction [bisphenol A results in decreased expression of CAT protein]; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT mRNA; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT protein |
CTD |
PMID:29129240 |
|
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
DNMT1 |
DNA methyltransferase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT1 mRNA |
CTD |
PMID:28445388 |
|
NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,566...69,029,844
|
|
G |
DNMT3A |
DNA methyltransferase 3 alpha |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT3A mRNA |
CTD |
PMID:28445388 |
|
NCBI chr 3:113,501,972...113,609,148
Ensembl chr 3:113,528,926...113,603,087
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of GPX1 mRNA; [bisphenol A co-treated with [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12]] results in increased expression of GPX1 mRNA |
CTD |
PMID:29129240 |
|
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433
|
|
G |
GYS1 |
glycogen synthase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Folic Acid co-treated with bisphenol A] results in increased methylation of GYS1 promoter; [Betaine co-treated with Choline co-treated with Folic Acid] results in decreased expression of GYS1 mRNA; [Betaine co-treated with Choline co-treated with Folic Acid] results in increased methylation of GYS1 promoter |
CTD |
PMID:29065941 |
|
NCBI chr 6:54,234,600...54,250,211
Ensembl chr 6:54,233,050...54,250,261
|
|
G |
LDHA |
lactate dehydrogenase A |
multiple interactions |
EXP |
[bisphenol A co-treated with Choline co-treated with Folic Acid co-treated with Betaine] results in decreased methylation of LDHA promoter |
CTD |
PMID:29065941 |
|
NCBI chr 2:40,814,163...40,827,284
Ensembl chr 2:40,814,169...40,826,715
|
|
G |
MTHFR |
methylenetetrahydrofolate reductase |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of MTHFR mRNA |
CTD |
PMID:28445388 |
|
NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,637...71,881,820
|
|
G |
SI |
sucrase-isomaltase |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SI mRNA |
CTD |
PMID:28445388 |
|
NCBI chr13:104,296,281...104,379,558
Ensembl chr13:104,296,283...104,379,478
|
|
G |
SLC15A1 |
solute carrier family 15 member 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of SLC15A1 mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased methylation of SLC15A1 promoter]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC15A1 mRNA |
CTD |
PMID:28445388 |
|
NCBI chr11:67,652,808...67,690,457
Ensembl chr11:67,652,193...67,710,933
|
|
G |
SLC5A1 |
solute carrier family 5 member 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with bisphenol A] results in increased expression of SLC5A1 mRNA; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC5A1 mRNA |
CTD |
PMID:28445388 |
|
NCBI chr14:48,566,400...48,704,145
Ensembl chr14:48,628,224...48,705,841
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of SOD1 mRNA |
CTD |
PMID:29129240 |
|
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
|
|
|
G |
CAT |
catalase |
multiple interactions |
EXP |
[Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] promotes the reaction [bisphenol A results in decreased expression of CAT protein]; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT mRNA; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT protein |
CTD |
PMID:29129240 |
|
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
CBS |
cystathionine beta-synthase |
multiple interactions increases activity |
EXP |
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of CBS protein Folic Acid deficiency results in increased activity of CBS protein |
CTD |
PMID:16792574 |
|
NCBI chr13:206,205,942...206,231,363
Ensembl chr13:206,205,946...206,230,248
|
|
G |
CSF2 |
colony stimulating factor 2 |
multiple interactions |
EXP |
[Folic Acid co-treated with Glycine] results in decreased expression of CSF2 mRNA |
CTD |
PMID:14662146 |
|
NCBI chr 2:134,354,724...134,357,155
Ensembl chr 2:134,354,724...134,357,155
|
|
G |
CTH |
cystathionine gamma-lyase |
multiple interactions |
EXP |
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of CTH protein |
CTD |
PMID:16792574 |
|
NCBI chr 6:142,454,922...142,486,352
Ensembl chr 6:142,454,914...142,486,367
|
|
G |
DNMT1 |
DNA methyltransferase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT1 mRNA |
CTD |
PMID:28445388 |
|
NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,566...69,029,844
|
|
G |
DNMT3A |
DNA methyltransferase 3 alpha |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT3A mRNA |
CTD |
PMID:28445388 |
|
NCBI chr 3:113,501,972...113,609,148
Ensembl chr 3:113,528,926...113,603,087
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
multiple interactions |
EXP |
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of GCLC protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GCLC mRNA |
CTD |
PMID:16792574 |
|
NCBI chr 7:27,209,565...27,253,535
Ensembl chr 7:27,209,565...27,253,530
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of GPX1 mRNA; [bisphenol A co-treated with [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12]] results in increased expression of GPX1 mRNA |
CTD |
PMID:29129240 |
|
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions increases activity increases expression |
EXP |
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of GSR protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSR mRNA Folic Acid deficiency results in increased activity of GSR protein Folic Acid deficiency results in increased expression of GSR mRNA |
CTD |
PMID:16792574 |
|
NCBI chr15:54,382,564...54,433,989
Ensembl chr15:54,382,567...54,433,984
|
|
G |
GSS |
glutathione synthetase |
multiple interactions |
EXP |
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of GSS protein; [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSS mRNA |
CTD |
PMID:16792574 |
|
NCBI chr17:38,316,199...38,342,253
Ensembl chr17:38,312,720...38,342,298
|
|
G |
GSTA1 |
glutathione S-transferase alpha 1 |
increases expression multiple interactions |
EXP |
Folic Acid deficiency results in increased expression of GSTA1 mRNA [Ethanol co-treated with Folic Acid deficiency] results in increased expression of GSTA1 mRNA |
CTD |
PMID:16792574 |
|
NCBI chr 7:46,538,743...46,550,781
Ensembl chr 7:46,538,032...46,548,670
|
|
G |
GYS1 |
glycogen synthase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Folic Acid co-treated with bisphenol A] results in increased methylation of GYS1 promoter; [Betaine co-treated with Choline co-treated with Folic Acid] results in decreased expression of GYS1 mRNA; [Betaine co-treated with Choline co-treated with Folic Acid] results in increased methylation of GYS1 promoter |
CTD |
PMID:29065941 |
|
NCBI chr 6:54,234,600...54,250,211
Ensembl chr 6:54,233,050...54,250,261
|
|
G |
LDHA |
lactate dehydrogenase A |
multiple interactions |
EXP |
[bisphenol A co-treated with Choline co-treated with Folic Acid co-treated with Betaine] results in decreased methylation of LDHA promoter |
CTD |
PMID:29065941 |
|
NCBI chr 2:40,814,163...40,827,284
Ensembl chr 2:40,814,169...40,826,715
|
|
G |
MTHFR |
methylenetetrahydrofolate reductase |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of MTHFR mRNA |
CTD |
PMID:28445388 |
|
NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,637...71,881,820
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
EXP |
[Folic Acid co-treated with Glycine] results in decreased expression of PTGS1 |
CTD |
PMID:14662146 |
|
NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[Folic Acid co-treated with Glycine] results in increased expression of PTGS2 |
CTD |
PMID:14662146 |
|
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
|
|
G |
SI |
sucrase-isomaltase |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SI mRNA |
CTD |
PMID:28445388 |
|
NCBI chr13:104,296,281...104,379,558
Ensembl chr13:104,296,283...104,379,478
|
|
G |
SLC15A1 |
solute carrier family 15 member 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of SLC15A1 mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased methylation of SLC15A1 promoter]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC15A1 mRNA |
CTD |
PMID:28445388 |
|
NCBI chr11:67,652,808...67,690,457
Ensembl chr11:67,652,193...67,710,933
|
|
G |
SLC5A1 |
solute carrier family 5 member 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with bisphenol A] results in increased expression of SLC5A1 mRNA; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC5A1 mRNA |
CTD |
PMID:28445388 |
|
NCBI chr14:48,566,400...48,704,145
Ensembl chr14:48,628,224...48,705,841
|
|
G |
SOD1 |
superoxide dismutase 1 |
decreases activity multiple interactions |
EXP |
Folic Acid deficiency results in decreased activity of SOD1 protein [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of SOD1 mRNA; [Ethanol co-treated with Folic Acid deficiency] results in decreased activity of SOD1 protein |
CTD |
PMID:16792574 PMID:29129240 |
|
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions increases activity |
EXP |
[Ethanol co-treated with Folic Acid deficiency] results in increased activity of SOD2 protein Folic Acid deficiency results in increased activity of SOD2 protein; Folic Acid results in increased activity of SOD2 protein |
CTD |
PMID:16792574 PMID:22889112 |
|
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
|
|
|
G |
CACNA2D1 |
calcium voltage-gated channel auxiliary subunit alpha2delta 1 |
affects binding |
EXP |
Gabapentin binds to CACNA2D1 protein |
CTD |
PMID:11687876 |
|
NCBI chr 9:97,781,057...98,265,925
Ensembl chr 9:97,781,090...98,266,969
|
|
|
G |
AIFM1 |
apoptosis inducing factor mitochondria associated 1 |
multiple interactions |
EXP |
Glycine inhibits the reaction [monobutyl phthalate results in increased expression of AIFM1 mRNA] |
CTD |
PMID:35839969 |
|
NCBI chr X:106,676,596...106,708,290
Ensembl chr X:106,670,520...106,708,317
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
Glycine inhibits the reaction [monobutyl phthalate results in increased expression of BAX mRNA] |
CTD |
PMID:35839969 |
|
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,147
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP |
Glycine inhibits the reaction [monobutyl phthalate results in increased expression of and results in increased activity of CASP3 protein]; Glycine inhibits the reaction [monobutyl phthalate results in increased expression of CASP3 mRNA] |
CTD |
PMID:35839969 |
|
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
|
|
G |
CAT |
catalase |
multiple interactions |
EXP |
Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of CAT mRNA] |
CTD |
PMID:35839969 |
|
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
CDC26 |
cell division cycle 26 |
multiple interactions |
EXP |
Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of CDC26 mRNA] |
CTD |
PMID:35839969 |
|
NCBI chr 1:253,893,666...253,906,659
Ensembl chr 1:253,895,885...253,906,632
|
|
G |
CSF2 |
colony stimulating factor 2 |
multiple interactions |
EXP |
[Folic Acid co-treated with Glycine] results in decreased expression of CSF2 mRNA |
CTD |
PMID:14662146 |
|
NCBI chr 2:134,354,724...134,357,155
Ensembl chr 2:134,354,724...134,357,155
|
|
G |
MFN1 |
mitofusin 1 |
multiple interactions |
EXP |
Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of MFN1 mRNA]; Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of MFN1 protein] |
CTD |
PMID:35839969 |
|
NCBI chr13:117,404,637...117,441,750
Ensembl chr13:117,404,699...117,442,481
|
|
G |
MFN2 |
mitofusin 2 |
multiple interactions |
EXP |
Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of MFN2 mRNA]; Glycine inhibits the reaction [monobutyl phthalate results in decreased expression of MFN2 protein] |
CTD |
PMID:35839969 |
|
NCBI chr 6:72,026,512...72,056,439
Ensembl chr 6:72,028,499...72,056,438
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
EXP |
[Folic Acid co-treated with Glycine] results in decreased expression of PTGS1 |
CTD |
PMID:14662146 |
|
NCBI chr 1:262,456,106...262,482,159
Ensembl chr 1:262,456,155...262,483,035
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[Folic Acid co-treated with Glycine] results in increased expression of PTGS2 |
CTD |
PMID:14662146 |
|
NCBI chr 9:127,850,164...127,858,866
Ensembl chr 9:127,850,015...127,858,884
|
|
G |
TUBA1B |
tubulin alpha 1b |
multiple interactions |
EXP |
Glycine inhibits the reaction [monobutyl phthalate results in increased expression of TUBA1B mRNA] |
CTD |
PMID:35839969 |
|
NCBI chr 5:15,150,229...15,153,620
Ensembl chr 5:15,149,099...15,153,620
|
|
|
G |
ATF4 |
activating transcription factor 4 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of ATF4 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of ATF4 protein] |
CTD |
PMID:36584959 |
|
NCBI chr 5:8,742,964...8,745,752
Ensembl chr 5:8,742,967...8,745,368
|
|
G |
ATF6 |
activating transcription factor 6 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of ATF6 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr 4:88,591,279...88,806,156
Ensembl chr 4:88,591,288...88,805,304
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
[Betaine co-treated with Glyphosate] results in increased expression of BAX mRNA |
CTD |
PMID:36584959 |
|
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,147
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of CASP3 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
|
|
G |
CASP9 |
caspase 9 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of CASP9 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
|
|
G |
CAT |
catalase |
multiple interactions |
EXP |
[Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] promotes the reaction [bisphenol A results in decreased expression of CAT protein]; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT mRNA; [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of CAT protein; Betaine inhibits the reaction [Glyphosate results in increased expression of CAT mRNA] |
CTD |
PMID:29129240 PMID:36584959 |
|
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
CLDN1 |
claudin 1 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in decreased expression of CLDN1 mRNA]; Betaine inhibits the reaction [Glyphosate results in decreased expression of CLDN1 protein] |
CTD |
PMID:36584959 |
|
NCBI chr13:127,714,857...127,730,628
Ensembl chr13:127,712,777...127,730,657
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of DDIT3 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr 5:22,785,441...22,789,867
Ensembl chr 5:22,785,445...22,789,829
|
|
G |
DNMT1 |
DNA methyltransferase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT1 mRNA |
CTD |
PMID:28445388 |
|
NCBI chr 2:68,981,564...69,040,364
Ensembl chr 2:68,981,566...69,029,844
|
|
G |
DNMT3A |
DNA methyltransferase 3 alpha |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of DNMT3A mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of DNMT3A mRNA |
CTD |
PMID:28445388 |
|
NCBI chr 3:113,501,972...113,609,148
Ensembl chr 3:113,528,926...113,603,087
|
|
G |
EIF2AK3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2AK3 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2AK3 protein] |
CTD |
PMID:36584959 |
|
NCBI chr 3:57,423,894...57,506,247
Ensembl chr 3:57,423,943...57,506,245
|
|
G |
EIF2S1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2S1 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2S1 protein] |
CTD |
PMID:36584959 |
|
NCBI chr 7:91,085,025...91,109,835
Ensembl chr 7:91,085,335...91,109,827
|
|
G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of ERN1 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr12:14,881,913...14,963,290
Ensembl chr12:14,881,923...14,963,284
|
|
G |
GPX1 |
glutathione peroxidase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of GPX1 mRNA; [bisphenol A co-treated with [Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12]] results in increased expression of GPX1 mRNA |
CTD |
PMID:29129240 |
|
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433
|
|
G |
GPX2 |
glutathione peroxidase 2 |
multiple interactions |
EXP |
[Betaine co-treated with Glyphosate] results in increased expression of GPX2 mRNA |
CTD |
PMID:36584959 |
|
NCBI chr 7:89,007,636...89,011,620
Ensembl chr 7:89,007,375...89,011,620
|
|
G |
GYS1 |
glycogen synthase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Folic Acid co-treated with bisphenol A] results in increased methylation of GYS1 promoter; [Betaine co-treated with Choline co-treated with Folic Acid] results in decreased expression of GYS1 mRNA; [Betaine co-treated with Choline co-treated with Folic Acid] results in increased methylation of GYS1 promoter |
CTD |
PMID:29065941 |
|
NCBI chr 6:54,234,600...54,250,211
Ensembl chr 6:54,233,050...54,250,261
|
|
G |
HSP90B1 |
heat shock protein 90 beta family member 1 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of HSP90B1 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of HSP90B1 protein] |
CTD |
PMID:36584959 |
|
NCBI chr 5:80,511,513...80,531,016
Ensembl chr 5:80,511,506...80,530,991
|
|
G |
LDHA |
lactate dehydrogenase A |
multiple interactions |
EXP |
[bisphenol A co-treated with Choline co-treated with Folic Acid co-treated with Betaine] results in decreased methylation of LDHA promoter |
CTD |
PMID:29065941 |
|
NCBI chr 2:40,814,163...40,827,284
Ensembl chr 2:40,814,169...40,826,715
|
|
G |
MFN1 |
mitofusin 1 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of MFN1 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr13:117,404,637...117,441,750
Ensembl chr13:117,404,699...117,442,481
|
|
G |
MTHFR |
methylenetetrahydrofolate reductase |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of MTHFR mRNA |
CTD |
PMID:28445388 |
|
NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,637...71,881,820
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of NFE2L2 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of NQO1 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590
|
|
G |
PCNA |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of PCNA mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of PCNA protein] |
CTD |
PMID:36584959 |
|
NCBI chr17:14,137,746...14,142,584
Ensembl chr17:14,136,886...14,142,744
|
|
G |
SDHA |
succinate dehydrogenase complex flavoprotein subunit A |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of SDHA mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr16:79,838,442...79,862,956
Ensembl chr16:79,834,044...79,862,524
|
|
G |
SI |
sucrase-isomaltase |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SI mRNA |
CTD |
PMID:28445388 |
|
NCBI chr13:104,296,281...104,379,558
Ensembl chr13:104,296,283...104,379,478
|
|
G |
SLC15A1 |
solute carrier family 15 member 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased expression of SLC15A1 mRNA]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] inhibits the reaction [bisphenol A results in decreased methylation of SLC15A1 promoter]; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC15A1 mRNA |
CTD |
PMID:28445388 |
|
NCBI chr11:67,652,808...67,690,457
Ensembl chr11:67,652,193...67,710,933
|
|
G |
SLC5A1 |
solute carrier family 5 member 1 |
multiple interactions |
EXP |
[Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid co-treated with bisphenol A] results in increased expression of SLC5A1 mRNA; [Betaine co-treated with Choline co-treated with Vitamin B 12 co-treated with Folic Acid] results in increased expression of SLC5A1 mRNA |
CTD |
PMID:28445388 |
|
NCBI chr14:48,566,400...48,704,145
Ensembl chr14:48,628,224...48,705,841
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions |
EXP |
[Betaine co-treated with Folic Acid co-treated with Choline co-treated with Vitamin B 12] results in increased expression of SOD1 mRNA |
CTD |
PMID:29129240 |
|
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of SOD2 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
|
|
G |
UQCRB |
ubiquinol-cytochrome c reductase binding protein |
multiple interactions |
EXP |
[Betaine co-treated with Glyphosate] results in decreased expression of UQCRB mRNA |
CTD |
PMID:36584959 |
|
NCBI chr 4:40,403,272...40,409,080
Ensembl chr 4:40,403,109...40,409,057
|
|
G |
XBP1 |
X-box binding protein 1 |
multiple interactions |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of XBP1 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr14:46,011,239...46,016,526
Ensembl chr14:46,008,377...46,016,526
|
|
|
G |
ATF4 |
activating transcription factor 4 |
increases expression multiple interactions |
EXP |
Glyphosate results in increased expression of ATF4 mRNA; Glyphosate results in increased expression of ATF4 protein Betaine inhibits the reaction [Glyphosate results in increased expression of ATF4 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of ATF4 protein] |
CTD |
PMID:36584959 |
|
NCBI chr 5:8,742,964...8,745,752
Ensembl chr 5:8,742,967...8,745,368
|
|
G |
ATF6 |
activating transcription factor 6 |
multiple interactions increases expression |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of ATF6 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr 4:88,591,279...88,806,156
Ensembl chr 4:88,591,288...88,805,304
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
EXP |
[Betaine co-treated with Glyphosate] results in increased expression of BAX mRNA Glyphosate results in increased expression of BAX mRNA |
CTD |
PMID:36584959 |
|
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,147
|
|
G |
CASP3 |
caspase 3 |
multiple interactions increases expression |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of CASP3 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
|
|
G |
CASP9 |
caspase 9 |
multiple interactions increases expression |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of CASP9 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr 6:74,707,597...74,730,033
Ensembl chr 6:74,706,516...74,730,007
|
|
G |
CAT |
catalase |
increases expression multiple interactions increases activity |
EXP |
Glyphosate results in increased expression of CAT mRNA Betaine inhibits the reaction [Glyphosate results in increased expression of CAT mRNA] Glyphosate results in increased activity of CAT protein |
CTD |
PMID:31677563 PMID:36584959 |
|
NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452
|
|
G |
CLDN1 |
claudin 1 |
multiple interactions decreases expression |
EXP |
Betaine inhibits the reaction [Glyphosate results in decreased expression of CLDN1 mRNA]; Betaine inhibits the reaction [Glyphosate results in decreased expression of CLDN1 protein] Glyphosate results in decreased expression of CLDN1 mRNA; Glyphosate results in decreased expression of CLDN1 protein |
CTD |
PMID:31677563 PMID:36584959 |
|
NCBI chr13:127,714,857...127,730,628
Ensembl chr13:127,712,777...127,730,657
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
increases expression multiple interactions |
EXP |
Glyphosate results in increased expression of CXCL8 mRNA pyrrolidine dithiocarbamic acid inhibits the reaction [Glyphosate results in increased expression of CXCL8 mRNA] |
CTD |
PMID:35388968 |
|
NCBI chr 8:69,932,646...69,935,861
Ensembl chr 8:69,932,643...69,935,861
|
|
G |
DDIT3 |
DNA damage inducible transcript 3 |
multiple interactions increases expression |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of DDIT3 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr 5:22,785,441...22,789,867
Ensembl chr 5:22,785,445...22,789,829
|
|
G |
EIF2AK3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions increases expression |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2AK3 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2AK3 protein] Glyphosate results in increased expression of EIF2AK3 mRNA; Glyphosate results in increased expression of EIF2AK3 protein |
CTD |
PMID:36584959 |
|
NCBI chr 3:57,423,894...57,506,247
Ensembl chr 3:57,423,943...57,506,245
|
|
G |
EIF2S1 |
eukaryotic translation initiation factor 2 subunit alpha |
multiple interactions increases expression |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2S1 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of EIF2S1 protein] Glyphosate results in increased expression of EIF2S1 mRNA; Glyphosate results in increased expression of EIF2S1 protein |
CTD |
PMID:36584959 |
|
NCBI chr 7:91,085,025...91,109,835
Ensembl chr 7:91,085,335...91,109,827
|
|
G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
increases expression multiple interactions |
EXP |
Glyphosate results in increased expression of ERN1 mRNA Betaine inhibits the reaction [Glyphosate results in increased expression of ERN1 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr12:14,881,913...14,963,290
Ensembl chr12:14,881,923...14,963,284
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
decreases expression |
EXP |
Glyphosate results in decreased expression of GCLM mRNA |
CTD |
PMID:31677563 PMID:35388968 |
|
NCBI chr 4:123,371,198...123,390,130
Ensembl chr 4:123,371,193...123,390,131
|
|
G |
GPX1 |
glutathione peroxidase 1 |
decreases expression decreases activity |
EXP |
Glyphosate results in decreased expression of GPX1 mRNA Glyphosate results in decreased activity of GPX1 protein |
CTD |
PMID:31677563 PMID:35388968 |
|
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433
|
|
G |
GPX2 |
glutathione peroxidase 2 |
multiple interactions |
EXP |
[Betaine co-treated with Glyphosate] results in increased expression of GPX2 mRNA |
CTD |
PMID:36584959 |
|
NCBI chr 7:89,007,636...89,011,620
Ensembl chr 7:89,007,375...89,011,620
|
|
G |
GSTO1 |
glutathione S-transferase omega 1 |
increases expression |
EXP |
Glyphosate results in increased expression of GSTO1 mRNA |
CTD |
PMID:36584959 |
|
NCBI chr14:115,206,434...115,216,624
Ensembl chr14:115,206,188...115,216,613
|
|
G |
HMOX1 |
heme oxygenase 1 |
decreases expression multiple interactions increases expression |
EXP |
Glyphosate results in decreased expression of HMOX1 mRNA Glyphosate results in increased expression of and affects the localization of HMOX1 protein Glyphosate results in increased expression of HMOX1 mRNA |
CTD |
PMID:31677563 PMID:35388968 PMID:36584959 |
|
|
|
G |
HSP90B1 |
heat shock protein 90 beta family member 1 |
increases expression multiple interactions |
EXP |
Glyphosate results in increased expression of HSP90B1 mRNA; Glyphosate results in increased expression of HSP90B1 protein Betaine inhibits the reaction [Glyphosate results in increased expression of HSP90B1 mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of HSP90B1 protein] |
CTD |
PMID:36584959 |
|
NCBI chr 5:80,511,513...80,531,016
Ensembl chr 5:80,511,506...80,530,991
|
|
G |
IL10 |
interleukin 10 |
increases expression |
EXP |
Glyphosate results in increased expression of IL10 protein |
CTD |
PMID:36584959 |
|
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
|
|
G |
IL6 |
interleukin 6 |
increases expression multiple interactions affects secretion |
EXP |
Glyphosate results in increased expression of IL6 mRNA; Glyphosate results in increased expression of IL6 protein pyrrolidine dithiocarbamic acid inhibits the reaction [Glyphosate results in increased expression of IL6 mRNA] Glyphosate affects the secretion of IL6 protein |
CTD |
PMID:31677563 PMID:35388968 PMID:36584959 |
|
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
|
|
G |
KEAP1 |
kelch like ECH associated protein 1 |
decreases expression |
EXP |
Glyphosate results in decreased expression of KEAP1 mRNA |
CTD |
PMID:35388968 |
|
NCBI chr 2:69,280,940...69,290,267
Ensembl chr 2:69,276,336...69,294,382
|
|
G |
LOC110258578 |
interleukin-1 beta-like |
increases expression multiple interactions increases secretion |
EXP |
Glyphosate results in increased expression of IL1B mRNA; Glyphosate results in increased expression of IL1B protein pyrrolidine dithiocarbamic acid inhibits the reaction [Glyphosate results in increased expression of IL1B mRNA] Glyphosate results in increased secretion of IL1B protein |
CTD |
PMID:35388968 PMID:36584959 |
|
|
|
G |
MFN1 |
mitofusin 1 |
multiple interactions increases expression |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of MFN1 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr13:117,404,637...117,441,750
Ensembl chr13:117,404,699...117,442,481
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases expression |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of NFE2L2 mRNA]; Glyphosate results in increased expression of and affects the localization of NFE2L2 protein Glyphosate results in increased expression of NFE2L2 mRNA; Glyphosate results in increased expression of NFE2L2 protein |
CTD |
PMID:31677563 PMID:35388968 PMID:36584959 |
|
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
increases expression |
EXP |
Glyphosate results in increased expression of NFKB1 mRNA |
CTD |
PMID:31677563 PMID:35388968 |
|
NCBI chr 8:118,391,010...118,478,927
Ensembl chr 8:118,390,638...118,506,691
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
EXP |
Glyphosate results in decreased expression of and results in increased phosphorylation of NFKBIA protein |
CTD |
PMID:35388968 |
|
NCBI chr 7:64,508,119...64,510,754
Ensembl chr 7:64,507,822...64,511,277
|
|
G |
NOS2 |
nitric oxide synthase 2 |
increases expression |
EXP |
Glyphosate results in increased expression of NOS2 mRNA |
CTD |
PMID:35388968 |
|
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
NQO1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions |
EXP |
Glyphosate results in increased expression of NQO1 mRNA Betaine inhibits the reaction [Glyphosate results in increased expression of NQO1 mRNA] |
CTD |
PMID:31677563 PMID:35388968 PMID:36584959 |
|
NCBI chr 6:17,292,962...17,302,593
Ensembl chr 6:17,292,770...17,302,590
|
|
G |
PCNA |
proliferating cell nuclear antigen |
increases expression multiple interactions |
EXP |
Glyphosate results in increased expression of PCNA mRNA; Glyphosate results in increased expression of PCNA protein Betaine inhibits the reaction [Glyphosate results in increased expression of PCNA mRNA]; Betaine inhibits the reaction [Glyphosate results in increased expression of PCNA protein] |
CTD |
PMID:36584959 |
|
NCBI chr17:14,137,746...14,142,584
Ensembl chr17:14,136,886...14,142,744
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
increases phosphorylation |
EXP |
Glyphosate results in increased phosphorylation of RELA protein |
CTD |
PMID:35388968 |
|
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
|
|
G |
SDHA |
succinate dehydrogenase complex flavoprotein subunit A |
multiple interactions increases expression |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of SDHA mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr16:79,838,442...79,862,956
Ensembl chr16:79,834,044...79,862,524
|
|
G |
SOD1 |
superoxide dismutase 1 |
decreases activity |
EXP |
Glyphosate results in decreased activity of SOD1 protein |
CTD |
PMID:35388968 |
|
NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729
|
|
G |
SOD2 |
superoxide dismutase 2 |
increases expression multiple interactions |
EXP |
Glyphosate results in increased expression of SOD2 mRNA Betaine inhibits the reaction [Glyphosate results in increased expression of SOD2 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560
|
|
G |
SQSTM1 |
sequestosome 1 |
decreases expression multiple interactions |
EXP |
Glyphosate results in decreased expression of SQSTM1 protein Acetylcysteine inhibits the reaction [Glyphosate results in decreased expression of SQSTM1 protein] |
CTD |
PMID:35388968 |
|
NCBI chr 2:78,752,768...78,763,998
Ensembl chr 2:78,752,771...78,763,938
|
|
G |
TJP1 |
tight junction protein 1 |
decreases expression |
EXP |
Glyphosate results in decreased expression of TJP1 mRNA |
CTD |
PMID:31677563 |
|
NCBI chr 1:144,930,387...145,195,857
Ensembl chr 1:144,930,370...145,195,836
|
|
G |
TNF |
tumor necrosis factor |
affects secretion increases expression |
EXP |
Glyphosate affects the secretion of TNF protein Glyphosate results in increased expression of TNF protein |
CTD |
PMID:35388968 PMID:36584959 |
|
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
G |
UQCRB |
ubiquinol-cytochrome c reductase binding protein |
multiple interactions |
EXP |
[Betaine co-treated with Glyphosate] results in decreased expression of UQCRB mRNA |
CTD |
PMID:36584959 |
|
NCBI chr 4:40,403,272...40,409,080
Ensembl chr 4:40,403,109...40,409,057
|
|
G |
XBP1 |
X-box binding protein 1 |
multiple interactions increases expression |
EXP |
Betaine inhibits the reaction [Glyphosate results in increased expression of XBP1 mRNA] |
CTD |
PMID:36584959 |
|
NCBI chr14:46,011,239...46,016,526
Ensembl chr14:46,008,377...46,016,526
|
|
|
G |
HRH2 |
histamine receptor H2 |
multiple interactions |
EXP |
[Histamine affects the activity of HRH2 protein] which affects the secretion of Chlorides |
CTD |
PMID:12665126 |
|
NCBI chr 2:81,883,670...81,932,464
Ensembl chr 2:81,883,673...81,932,275
|
|
|
G |
BAX |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX mRNA] |
CTD |
PMID:38438008 |
|
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,147
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP |
theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 mRNA] |
CTD |
PMID:38438008 |
|
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
|
|
G |
CASP3 |
caspase 3 |
multiple interactions |
EXP |
theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 mRNA] |
CTD |
PMID:38438008 |
|
NCBI chr15:45,744,320...45,753,252
Ensembl chr15:45,742,751...45,764,213
|
|
G |
CLDN1 |
claudin 1 |
multiple interactions |
EXP |
[N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA]; [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of CLDN1 mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of CLDN1 protein]; theanine inhibits the reaction [Lipopolysaccharides results in decreased expression of CLDN1 mRNA] |
CTD |
PMID:37271275 PMID:38438008 |
|
NCBI chr13:127,714,857...127,730,628
Ensembl chr13:127,712,777...127,730,657
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
EXP |
theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of IL6 mRNA] |
CTD |
PMID:38438008 |
|
NCBI chr 9:91,506,421...91,510,830
Ensembl chr 9:91,506,421...91,511,263
|
|
G |
LDHA |
lactate dehydrogenase A |
multiple interactions |
EXP |
theanine inhibits the reaction [Hydrogen Peroxide results in increased activity of LDHA protein] |
CTD |
PMID:38438008 |
|
NCBI chr 2:40,814,163...40,827,284
Ensembl chr 2:40,814,169...40,826,715
|
|
G |
LOC110258578 |
interleukin-1 beta-like |
multiple interactions |
EXP |
[N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of IL1B mRNA]; theanine inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] |
CTD |
PMID:37271275 PMID:38438008 |
|
|
|
G |
MAPK14 |
mitogen-activated protein kinase 14 |
multiple interactions |
EXP |
[SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK14 mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of MAPK14 protein]; theanine inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK14 mRNA] |
CTD |
PMID:37271275 PMID:38438008 |
|
NCBI chr 7:31,791,398...31,861,544
Ensembl chr 7:31,790,877...31,862,031
|
|
G |
NLRP3 |
NLR family pyrin domain containing 3 |
multiple interactions |
EXP |
[N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA]; [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA]; theanine inhibits the reaction [Lipopolysaccharides results in increased expression of NLRP3 mRNA] |
CTD |
PMID:37271275 |
|
NCBI chr 2:56,892,241...56,977,412
Ensembl chr 2:56,892,243...56,977,228
|
|
G |
OCLN |
occludin |
multiple interactions |
EXP |
[N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA]; [SB 203580 co-treated with theanine] inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of OCLN protein]; theanine inhibits the reaction [Lipopolysaccharides results in decreased expression of OCLN mRNA] |
CTD |
PMID:37271275 PMID:38438008 |
|
NCBI chr16:47,600,175...47,652,435
Ensembl chr16:47,600,212...47,654,033
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
theanine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of RELA protein] |
CTD |
PMID:38438008 |
|
NCBI chr 2:6,594,869...6,602,684
Ensembl chr 2:6,593,969...6,603,469
|
|
G |
TJP1 |
tight junction protein 1 |
multiple interactions |
EXP |
theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of TJP1 mRNA]; theanine inhibits the reaction [Hydrogen Peroxide results in decreased expression of TJP1 protein] |
CTD |
PMID:38438008 |
|
NCBI chr 1:144,930,387...145,195,857
Ensembl chr 1:144,930,370...145,195,836
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
EXP |
theanine inhibits the reaction [Hydrogen Peroxide results in increased expression of TNF mRNA] |
CTD |
PMID:38438008 |
|
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,415
|
|
|
G |
ACE |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
multiple interactions |
EXP |
ACE protein inhibits the reaction [KNG1 protein results in increased abundance of Nitric Oxide] |
CTD |
PMID:12672649 |
|
NCBI chr12:15,394,487...15,414,609
Ensembl chr12:15,394,487...15,414,703
|
|
G |
AGT |
angiotensinogen |
affects activity |
EXP |
Nitric Oxide affects the activity of AGT protein |
CTD |
PMID:21127344 |
|
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
|
|
G |
BCL2 |
BCL2 apoptosis regulator |
multiple interactions |
EXP |
Nitric Oxide results in increased phosphorylation of and results in decreased activity of BCL2 protein |
CTD |
PMID:16039061 |
|
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
|
|
G |
CAPN1 |
calpain 1 |
decreases expression |
EXP |
Nitric Oxide results in decreased expression of CAPN1 mRNA |
CTD |
PMID:9728040 |
|
NCBI chr 2:6,997,513...7,024,410
Ensembl chr 2:6,997,985...7,022,684
|
|
G |
EDN1 |
endothelin 1 |
increases abundance multiple interactions |
EXP |
EDN1 protein results in increased abundance of Nitric Oxide Nitric Oxide deficiency inhibits the reaction [Clofibrate results in decreased expression of EDN1 protein] |
CTD |
PMID:12672649 PMID:17105827 |
|
NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348
|
|
G |
KNG1 |
kininogen 1 |
multiple interactions increases abundance |
EXP |
ACE protein inhibits the reaction [KNG1 protein results in increased abundance of Nitric Oxide] |
CTD |
PMID:12672649 |
|
NCBI chr13:124,521,276...124,557,384
Ensembl chr13:124,521,340...124,557,958
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
Resveratrol inhibits the reaction [NOS2 protein results in increased chemical synthesis of Nitric Oxide] |
CTD |
PMID:20825639 |
|
NCBI chr12:44,174,944...44,219,875
Ensembl chr12:44,174,948...44,218,146
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions decreases activity |
EXP |
TXNRD1 protein inhibits the reaction [Nitric Oxide results in decreased activity of NOS3 protein] |
CTD |
PMID:8810647 PMID:10823391 |
|
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
|
|
G |
TAC1 |
tachykinin precursor 1 |
increases abundance |
EXP |
TAC1 protein results in increased abundance of Nitric Oxide |
CTD |
PMID:12672649 |
|
NCBI chr 9:77,197,403...77,206,529
Ensembl chr 9:77,197,536...77,206,523
|
|
G |
TXNRD1 |
thioredoxin reductase 1 |
multiple interactions |
EXP |
TXNRD1 protein inhibits the reaction [Nitric Oxide results in decreased activity of NOS3 protein] |
CTD |
PMID:8810647 |
|
NCBI chr 5:80,170,334...80,213,889
Ensembl chr 5:80,172,260...80,236,219
|
|
|
G |
ABCB4 |
ATP binding cassette subfamily B member 4 |
increases export multiple interactions |
EXP |
ABCB4 protein results in increased export of Phosphatidylcholines Itraconazole inhibits the reaction [ABCB4 protein results in increased export of Phosphatidylcholines]; Verapamil inhibits the reaction [ABCB4 protein results in increased export of Phosphatidylcholines] |
CTD |
PMID:21056966 |
|
NCBI chr 9:93,171,371...93,262,124
|
|
G |
PDIA3 |
protein disulfide isomerase family A member 3 |
increases hydrolysis |
EXP |
PDIA3 protein results in increased hydrolysis of Phosphatidylcholines |
CTD |
PMID:16798117 |
|
NCBI chr 1:127,786,174...127,814,096
Ensembl chr 1:127,785,772...127,814,196
|
|
|
G |
FOS |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
EXP |
Serotonin results in increased expression of FOS mRNA; Serotonin results in increased expression of FOS protein sarpogrelate inhibits the reaction [Serotonin results in increased expression of FOS mRNA]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of FOS protein] |
CTD |
PMID:11426759 |
|
NCBI chr 7:98,449,508...98,451,971
Ensembl chr 7:98,449,349...98,455,554
|
|
G |
JUN |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions increases expression |
EXP |
sarpogrelate inhibits the reaction [Serotonin results in increased expression of JUN mRNA]; sarpogrelate inhibits the reaction [Serotonin results in increased expression of JUN protein] Serotonin results in increased expression of JUN mRNA; Serotonin results in increased expression of JUN protein |
CTD |
PMID:11426759 |
|
NCBI chr 6:153,686,425...153,687,635
Ensembl chr 6:153,685,682...153,687,636
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
increases phosphorylation multiple interactions |
EXP |
Serotonin results in increased phosphorylation of MAPK1 protein sarpogrelate inhibits the reaction [Serotonin results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:11426759 |
|
NCBI chr14:50,083,079...50,165,528
Ensembl chr14:50,082,896...50,165,513
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation |
EXP |
sarpogrelate inhibits the reaction [Serotonin results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:11426759 |
|
NCBI chr 3:18,291,444...18,299,410
Ensembl chr 3:18,291,445...18,299,567
|
|